Back to top
more

Patterson Companies (PDCO)

(Delayed Data from NSDQ)

$21.05 USD

21.05
955,878

+0.25 (1.20%)

Updated Nov 11, 2024 04:00 PM ET

After-Market: $21.05 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 35% (88 out of 250)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Moving Average Crossover Alert: Patterson Companies

by Zacks Equity Research

Patterson Companies, Inc. (PDCO) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

Dentsply (XRAY) Soars to 52-Week High, Time to Cash Out?

by Zacks Equity Research

Dentsply (XRAY) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Masimo Posts Solid Preliminary 2019 Results, Issues Guidance

by Zacks Equity Research

Higher revenues and upbeat 2020 outlook benefit Masimo's (MASI) preliminary full-year 2019 results.

Should Value Investors Buy Patterson Cos. (PDCO) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Baxter Posts Upbeat Q4 Preliminary Results, Issues Guidance

by Zacks Equity Research

Higher revenues, growth in all geographic segments and six business units benefit Baxter's (BAX) Q4 preliminary operating results.

Here's Why You Should Hold on to Cardinal Health Stock Now

by Zacks Equity Research

Cardinal Health (CAH) is gaining from diversified product portfolio and robust pharmaceutical segment. However, integration risks remain a concern.

PDCO or WST: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

PDCO vs. WST: Which Stock Is the Better Value Option?

Intuitive Surgical (ISRG) Up on Solid Preliminary Q4 Results

by Zacks Equity Research

Higher revenues and growth in worldwide da Vinci procedure volume benefit Intuitive Surgical's (ISRG) preliminary Q4 results.

Veeva Systems Boosts Product Portfolio With New Application

by Zacks Equity Research

Veeva Systems (VEEV) introduces Veeva Vault Payments, which is likely to bolster the company's already robust product portfolio.

Here's Why You Should Invest in HMS Holdings (HMSY) Stock Now

by Zacks Equity Research

HMS Holdings (HMSY) is gaining traction from the growing PI and TPM analytical services.

Why Is Patterson Cos. (PDCO) Down 11.8% Since Last Earnings Report?

by Zacks Equity Research

Patterson Cos. (PDCO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Invest in Patterson Companies Stock Now

by Zacks Equity Research

Patterson Companies (PDCO) continues to benefit from robust product portfolio, strong prospects in Animal Health unit and strategic buyouts.

Should Value Investors Buy Patterson Cos. (PDCO) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

The Zacks Analyst Blog Highlights: Delek, Artisan Partners, Patterson and Waddell & Reed

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Delek, Artisan Partners, Patterson and Waddell & Reed

PDCO vs. CNMD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Supriyo Bose headshot

4 Value Stocks With Solid Dividend Yield to Buy in 2020

by Supriyo Bose

A sneak peek into some possible value stock outperformers with a solid Zacks Rank, healthy dividend yield and a favorable Zacks Industry Rank will likely help investors in 2020.

Is Patterson Cos. (PDCO) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

PDCO vs. WST: Which Stock Is the Better Value Option?

by Zacks Equity Research

PDCO vs. WST: Which Stock Is the Better Value Option?

Patterson Companies (PDCO) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Patterson Companies' (PDCO) Q2 results benefit from higher revenues, gross margin expansion and solid show by Dental segment.

Patterson Cos. (PDCO) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Patterson Cos. (PDCO) delivered earnings and revenue surprises of 11.43% and 0.19%, respectively, for the quarter ended October 2019. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Patterson Companies' (PDCO) Q2 Earnings?

by Zacks Equity Research

Patterson Companies (PDCO) has likely gained from strength in Animal Health segment in the fiscal second quarter.

Earnings Preview: Patterson Cos. (PDCO) Q2 Earnings Expected to Decline

by Zacks Equity Research

Patterson Cos. (PDCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What's in Store for Tandem Diabetes' (TNDM) Q3 Earnings?

by Zacks Equity Research

Growth in t:slim X2 insulin pump sales is expected to get reflected in Tandem Diabetes' (TNDM) upcoming quarterly results.

PerkinElmer (PKI) to Report Q3 Earnings: What's in Store?

by Zacks Equity Research

Top-line growth and robust performance at Diagnostics segment are likely to have aided PerkinElmer's (PKI) Q3 earnings. However, forex is likely to have been a dampener.

ABIOMED (ABMD) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

ABIOMED (ABMD) expects to have gained from its flagship Impella product line in fiscal Q2.